- Investing Ideas
- /
- Materials Healthcare Sector
Materials Healthcare Sector
Results
2309
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,309 companies
ProMIS Neurosciences
Market Cap: US$16.8m
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada.
PMN
US$0.51
7D
2.3%
1Y
-72.2%
Kenilworth Systems
Market Cap: US$16.7m
Provides medical travel consulting and referral services.
KENS
US$0.20
7D
-25.9%
1Y
-16.7%
Elevation Oncology
Market Cap: US$16.7m
An oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs.
ELEV
US$0.28
7D
-17.6%
1Y
-92.2%
BriaCell Therapeutics
Market Cap: CA$23.3m
A clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.
BCT
CA$4.08
7D
-6.0%
1Y
-85.5%
American Shared Hospital Services
Market Cap: US$16.6m
Provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services.
AMS
US$2.57
7D
-8.2%
1Y
-24.9%
Leap Therapeutics
Market Cap: US$16.5m
A biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer.
LPTX
US$0.40
7D
19.7%
1Y
-84.8%
Bullfrog AI Holdings
Market Cap: US$16.5m
Through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States.
BFRG
US$1.75
7D
-0.6%
1Y
-38.6%
Neurotech International
Market Cap: AU$25.7m
A clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices and solutions in Australia.
NTI
AU$0.025
7D
6.5%
1Y
-68.6%
NeurAxis
Market Cap: US$16.2m
A medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.
NRXS
US$2.25
7D
12.5%
1Y
-26.0%
ProPhase Labs
Market Cap: US$16.2m
Develops and commercializes novel drugs, dietary supplements, and compounds in the United States.
PRPH
US$0.39
7D
27.7%
1Y
-92.3%
Amplia Therapeutics
Market Cap: AU$25.2m
A clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia.
ATX
AU$0.065
7D
20.4%
1Y
12.1%
Next Science
Market Cap: AU$25.1m
Engages in the research, development, and commercialization of technologies that resolve the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand.
NXS
AU$0.086
7D
-13.1%
1Y
-72.7%
Beyond Air
Market Cap: US$16.1m
A commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform.
XAIR
US$0.18
7D
-7.2%
1Y
-86.7%
GlycoMimetics
Market Cap: US$15.9m
Engages in the discovery and development of therapies for cancers and inflammatory diseases in the United States.
GLYC
US$0.25
7D
2.8%
1Y
-17.5%
PharmChem
Market Cap: US$15.8m
Provides PharmChek Sweat Patch that is used to detect drugs of abuse.
PCHM
US$3.40
7D
14.5%
1Y
25.9%
Trinity Biotech
Market Cap: US$15.7m
Acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland.
TRIB
US$0.85
7D
12.4%
1Y
-46.4%
REMSleep Holdings
Market Cap: US$15.4m
A medical technology company, focuses on the development and distribution of products to help people affected by sleep apnea worldwide.
RMSL
US$0.01
7D
17.9%
1Y
-40.4%
DH Enchantment
Market Cap: US$15.3m
Through its subsidiary, Ho Shun Yi Limited, engages in the sale and distribution of COVID-19 rapid antigen tester sets in Hong Kong.
ENMI
US$0.004
7D
0%
1Y
185.7%
Relmada Therapeutics
Market Cap: US$15.3m
Operates as a clinical-stage biotechnology company in the United States.
RLMD
US$0.46
7D
9.9%
1Y
-86.2%
Nova Leap Health
Market Cap: CA$21.4m
Provides home and home health care services in the United States and Canada.
NLH
CA$0.24
7D
-2.0%
1Y
-18.3%
Avem Health Partners
Market Cap: US$15.2m
Provides financial, technology, management, and capital solutions to hospitals in rural markets.
FPCG
US$1,025.00
7D
0%
1Y
n/a
Exlites Holdings International
Market Cap: US$15.0m
Manufactures and distributes medical products.
EXHI
US$0.34
7D
0%
1Y
n/a
Harvard Bioscience
Market Cap: US$15.0m
Develops, manufactures, and sells technologies, products, and services for life science applications in the United States, Germany, and internationally.
HBIO
US$0.34
7D
7.8%
1Y
-89.9%
Vivos Therapeutics
Market Cap: US$15.0m
Operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.
VVOS
US$2.54
7D
-15.3%
1Y
10.9%
EMV Capital
Market Cap: UK£11.2m
A venture capital firm specializing in seed, growth capital, early and mid stage investments.
EMVC
UK£0.41
7D
6.6%
1Y
-41.3%
Zeo ScientifiX
Market Cap: US$14.9m
A clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicines.
ZEOX
US$2.35
7D
-11.3%
1Y
126.0%
Calidi Biotherapeutics
Market Cap: US$14.9m
A clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States.
CLDI
US$0.41
7D
-10.7%
1Y
-82.0%
Advanced Health Intelligence
Market Cap: AU$22.6m
Operates as a mobile application and technology development company in Australia and internationally.
AHI
AU$0.092
7D
0%
1Y
15.0%
ProBiotix Health
Market Cap: UK£11.1m
Develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally.
PBX
UK£0.07
7D
0%
1Y
64.7%
Ventripoint Diagnostics
Market Cap: CA$20.4m
A medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide.
VPT
CA$0.13
7D
-7.4%
1Y
-43.2%
Rallybio
Market Cap: US$14.6m
A clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases.
RLYB
US$0.35
7D
19.5%
1Y
-80.2%
Proteome Sciences
Market Cap: UK£10.9m
Provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally.
PRM
UK£0.037
7D
30.3%
1Y
-5.1%
Unidoc Health
Market Cap: CA$20.2m
Operates as a healthcare services company in Canada.
UDOC
CA$0.27
7D
-14.5%
1Y
-56.6%
Cocrystal Pharma
Market Cap: US$14.4m
A biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States.
COCP
US$1.42
7D
-6.6%
1Y
-27.2%
Psychemedics
Market Cap: US$14.4m
Engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally.
PMDI
US$2.36
7D
4.4%
1Y
-8.5%
Cingulate
Market Cap: US$14.4m
A biopharmaceutical company, develops pharmaceutical products for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States.
CING
US$3.82
7D
-4.7%
1Y
-60.3%